Rotavirus vaccine bovine reassortant (Serum Institute of India)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRotavirus vaccine bovine reassortant (Serum Institute of India)

Drug Alias NameLive attenuated bovine-human reassortant rotavirus vaccine牛轮状病毒疫苗株 - 印度血清研究所轮状病毒疫苗牛重配体 - 印度血清研究所Bovine reassortant rotavirus vaccineROTASIIL +[7]

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Live attenuated vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsGastroenteritisRotavirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIndia

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesSerum Institute Of India Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSerum Institute Of India Pvt Ltd

Active IndicationsRotavirus Infections

Inactive IndicationsGastroenteritis

Other Information

ATC CodeJ07BH01